Back
Outlook Therapeutics Vs. GT Biopharma Industry Stock Comparison
Sell
25
OTLK
Outlook Therapeutics
Last Price:
7.04
Seasonality Move:
-25.77%
Sell
41
GTBP
GT Biopharma
Last Price:
3.72
Seasonality Move:
6.67%
Sell
25
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy, Sell or Hold?
- The current Outlook Therapeutics [OTLK] share price is $7.06. The Score for OTLK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $3.75. The Score for GTBP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- GTBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OTLK Stock Price Chart
What is Outlook Therapeutics's stock price today?
-
The Outlook Therapeutics share price today is $7.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing slight selling pressure.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $3.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing selling pressure, which indicates risk of future bearish movement.
OTLK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 37.74 | Sell |
Chaikin Money Flow: | -40299 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.37 - 8.47) | Sell |
Bollinger Bands (100): | (7.34 - 9.06) | Sell |
GTBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 48.96 | Sell |
Chaikin Money Flow: | -9218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.65 - 4.71) | Buy |
Bollinger Bands (100): | (3.37 - 5.67) | Sell |
OTLK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.58 | Sell |
20-day SMA: | 7.73 | Sell |
50-day SMA: | 8.41 | Sell |
200-day SMA: | 8.75 | Sell |
8-day EMA: | 7.45 | Sell |
20-day EMA: | 7.73 | Sell |
50-day EMA: | 8.07 | Sell |
200-day EMA: | 11.01 | Sell |
GTBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.12 | Sell |
20-day SMA: | 3.8 | Sell |
50-day SMA: | 3.87 | Sell |
200-day SMA: | 6.01 | Sell |
8-day EMA: | 3.93 | Sell |
20-day EMA: | 3.9 | Sell |
50-day EMA: | 4.01 | Sell |
200-day EMA: | 7.94 | Sell |
Outlook Therapeutics Earnings Growth & OTLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.38 per share, an increase this year of $0.74 per share, and an increase next year of $1.74 per share.
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Outlook Therapeutics Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GT Biopharma Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |